These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6799174)

  • 21. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
    Binswanger U; Schiffl H; Huggler M; Becker C
    Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
    Massry SG; Tuma S; Dua S; Goldstein DA
    J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
    Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
    Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiological investigation of alterations in the rat femur after long-term immobilization.
    Gyarmati J; Jenei F; Földes I; Rapcsák M; Szöör A; Szilágyi T
    Acta Physiol Hung; 1987; 70(4):357-62. PubMed ID: 3439469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3.
    Nakamura T; Kurokawa T; Orimo H
    Bone; 1989; 10(2):117-23. PubMed ID: 2788448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3.
    Nakamura T; Kurokawa T; Orimo H
    Calcif Tissue Int; 1988 Oct; 43(4):235-43. PubMed ID: 3145129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
    Hinek A; Poole AR
    J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
    Davies M; Mawer EB; Adams PH
    J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis.
    Matsumoto T; Ezawa I; Morita K; Kawanobe Y; Ogata E
    J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S61-5. PubMed ID: 3915757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of 24,25-dioxycholecalciferol on calcium-phosphorus metabolism and bone tissue in rats with experimental renal failure].
    Alekseeva IA
    Vopr Pitan; 1984; (3):55-8. PubMed ID: 6332422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitonin treatment of immobilization osteoporosis in rats.
    Tuukkanen J; Jalovaara P; Väänänen K
    Acta Physiol Scand; 1991 Jan; 141(1):119-24. PubMed ID: 2053438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
    Queille ML; Miravet L; Bordier P; Redel J
    Biomedicine; 1978; 28(4):237-42. PubMed ID: 737274
    [No Abstract]   [Full Text] [Related]  

  • 35. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The difference of biological activity among four diastereoisomers of 1 alpha,25-dihydroxycholecalciferol-26,23-lactone.
    Ishizuka S; Norman AW
    J Steroid Biochem; 1986 Oct; 25(4):505-10. PubMed ID: 3022075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of osteoporosis in Japan.
    Fujita T
    Metabolism; 1990 Apr; 39(4 Suppl 1):39-42. PubMed ID: 2325570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of 24,25-dihydroxycholecalciferol in bone mineralization under hypokinesia in the rat].
    Sergeev IN; Blazheevich NV; Belakovskiĭ MS; Spirichev VB; Ushakov AS
    Kosm Biol Aviakosm Med; 1982; 16(5):74-7. PubMed ID: 6983003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25-Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats.
    Garabedian M; Pezant E; Miravet L; Fellot C; Balsan S
    Endocrinology; 1976 Mar; 98(3):794-9. PubMed ID: 1261499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative effectiveness of vitamin D metabolites in increasing bone mineral solubility.
    Somerman MJ; Neuman WF
    Calcif Tissue Int; 1981; 33(2):159-65. PubMed ID: 6783272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.